Viewing Study NCT03873818


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-01-26 @ 7:10 PM
Study NCT ID: NCT03873818
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-27
First Post: 2019-02-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clinical Stage IV Cutaneous Melanoma AJCC v8 View
None Metastatic Malignant Neoplasm in the Brain View
None Metastatic Melanoma View
None Pathologic Stage IV Cutaneous Melanoma AJCC v8 View
Keywords: